Pemetrexed disodium hemipenta hydrate 抗叶酸和抗代谢剂

¥500
进口
美国
2021-11-15 15:10

上海恒斐生物科技有限公司

我要认领
上海恒斐生物科技有限公司
刘鑫
17317793691 021-61843644
845206284@qq.com
845206284
产品属性
数量现货
英文名Pemetrexed disodium hemipenta hydrate
CAS号357166-30-4
供应商上海恒斐生物科技有限公司
保存条件-20
规格100mg
产品说明
357166-30-4 Pemetrexed disodium hemipenta hydrate 抗叶酸和抗代谢剂 货号A3707

Pemetrexed disodium hemipenta hydrate化学性质

CAS号357166-30-4SDFDownload SDF
别名Pemetrexed sodium hydrate (1:2:2.5)
化学名tetrasodium;(2S)-2-[[4-[2-(2-amino-4-oxo-1,7-dihydropyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]amino]pentanedioate;pentahydrate
SMILESC1=CC(=CC=C1CCC2=CNC3=C2C(=O)N=C(N3)N)C(=O)NC(CCC(=O)O)C(=O)O.O.[Na+]
分子式C20H23N5NaO7+分子量468.42
溶解性Soluble in Water储存条件Store at -20°C
运输条件试用装:蓝冰运输。
其他可选规格:常温运输或根据您的要求用蓝冰运输。
一般建议为了使其更好的溶解,请用37℃加热试管并在超声波水浴中震动片刻。不同厂家不同批次产品溶解度各有差异,仅做参考。若实验所需浓度过大至产品溶解极限,请添加助溶剂助溶或自行调整浓度。

Pemetrexed disodium hemipenta hydrate产品描述

IC50 Value: 1.3nM(Ki for TS); 7.2nM(DHFR); 65nM(GARFT) Pemetrexed is approved as a first-line treatment for advanced non-squamous non-small cell lung cancer (NSCLC) with cisplatin and as a single agent for second-line treatment or for patients who show no disease progression after four cycles of platinum-based doublet induction chemotherapy as maintenance therapy. in vitro: The Ki values of the pentaglutamate of LY231514 are 1.3, 7.2, and 65 nM for inhibition against TS, DHFR, and GARFT, respectively. In contrast, although a similar high level of inhibitory potency was observed for the parent monoglutamate against DHFR (7.0 nM), the inhibition constants (Ki) for the parent monoglutamate are significantly weaker for TS (109 nM) and GARFT(9,300 nM).The parent monoglutamate LY231514 inhibited rhTS with a Ki of 109 nM when the monoglutamated form of the substrate (6R-MTHF) (6[R]-5,l0-meth ylenetetrahydrofolate) was used. This is in good agreement with the Ki value generated earlier for rmTS (Ki= 340 nM)[1]. in vivo: pemetrexed effectively reduces kidney uptake of radiofolates not only in xenografted mice but also ina syngeneic tumor mouse model[2], Clinical trial: Phase 2 study of pemetrexed and itraconazole as second-line therapy for metastatic nonsquamous non-small-cell lung cancer is reported[3]
Pemetrexed disodium hemipenta hydrate
上海恒斐生物现货供应说明书及抑制剂详情请联系上海恒斐生物021-60493872 刘鑫 17317793691(微信同步)QQ845206284